DA
ABBV icon

Duality Advisers’s AbbVie ABBV Stock Holding History

Duality Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,728
Closed -$4.14M – 534
2023
Q2 		$4.14M Sell
30,728
-2,550
-8% -$374K 0.52% 31
2023
Q1 		$5.3M Buy
+33,278
New +$5.09M 0.6% 10
2022
Q2 		– Sell
-2,183
Closed -$354K – 574
2022
Q1 		$354K Buy
+2,183
New +$317K 0.04% 526

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Duality Advisers's ABBV Position: Q3 2023 in Review

Duality Advisers sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 30,728 shares — an estimated $4.14M sold.

Duality Advisers first reported a position in ABBV in Q1 2022 and held it in 3 quarters. The position peaked at $5.3M in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Duality Advisers reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Duality Advisers sold 30,728 AbbVie shares in Q3 2023, an estimated $4.14M.
  • Duality Advisers first reported a position in AbbVie in Q1 2022 and held it in 3 quarters.
  • Duality Advisers's AbbVie position peaked at $5.3M in Q1 2023.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.